Targeted therapy (tumor-kill) is only a small piece of what we should call personalized cancer medicine. A huge part of personalized cancer therapy should be other drugs, tumor-non-chemo interaction and drug/chemo-non-cancer disease interaction. Patient-specific factors, like age/weight/etc, are equally important (not to mention details such as BM pattern). Unless all the reports uploaded on your page bring sufficient detail to understand this "other" content, the information does not bring a confirmed association and it will be risky to reproduce it in another patient unless all other patient-related factors are similar.

Alice, I totally agree this SHOULD be an important part of precision cancer medicine, but:

1. No way we can request that the entire medication history of the patient will be recorded. Not even active medication. It could be a lot, and the oncologist may not have the information.

2. Are these factors really taken into consideration today? Do you know of therapeutic decisions that are influenced by non-cancer drugs? That use blood marker patterns to choose one therapy over another? (barring known cancer markers such as PSA, which we SHOULD add)

Eitan